GNH USA

Europe — EMA

Octaplex

GNH USA supplies Octaplex (Human Prothrombin Complex Concentrate), a prothrombin complex concentrate for warfarin reversal bleeding control. Request a quote.

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Human Prothrombin Complex Concentrate, the active ingredient in Octaplex, is a prothrombin complex concentrate presented as an injectable solution for intravenous use. It provides vitamin K‑dependent clotting factors II, VII, IX, X together with proteins C and S to rapidly reverse warfarin anticoagulation, treat bleeding episodes, and replace deficient proteins in acquired or congenital deficiencies.

GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and specialty clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics for this injectable product.

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?

Octaplex, a prothrombin complex concentrate, acts on the vitamin K‑dependent coagulation pathway to restore clotting ability.

- Urgent reversal of warfarin anticoagulation: rapidly restores clotting factors to counteract vitamin K antagonist effect. - Bleeding episodes in factor deficiencies: supplies missing factors II, VII, IX, and X to achieve hemostasis. - Protein C or protein S deficiency management: replaces deficient proteins to normalize anticoagulant balance.

What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Octaplex may be associated with infusion‑related reactions and rare serious events.

Common Side Effects: - Injection site erythema or pain - Fever or chills - Headache - Nausea or vomiting - Mild hypotension

Serious or Rare Side Effects: - Thromboembolic events (deep vein thrombosis, pulmonary embolism) - Disseminated intravascular coagulation - Severe allergic reactions or anaphylaxis - Hemolysis - Transmission of infectious agents (theoretical risk)

What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Before administering Octaplex, clinicians should observe the following precautions.

- Indication verification: confirm the patient requires rapid reversal of vitamin K antagonist or factor replacement. - Allergy assessment: check for known hypersensitivity to plasma‑derived products. - Thrombotic risk monitoring: observe for signs of thrombosis during and after infusion. - Dose adjustment: base dosing on coagulation test results and clinical response. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?

Octaplex can interact with other agents that affect coagulation.

Major Interactions (Avoid): - Concurrent anticoagulant therapy (e.g., heparin, direct oral anticoagulants): may diminish reversal efficacy. - Use of additional procoagulant agents (e.g., recombinant factor VIIa): increases risk of thrombosis.

Moderate Interactions (Monitor Closely): - Vitamin K supplementation: may alter the required dose of Octaplex. - Antiplatelet drugs (e.g., aspirin, clopidogrel): monitor bleeding status. - High‑dose steroids: may affect plasma protein levels and infusion tolerance.

Frequently asked questions

What is Octaplex used for?+
Octaplex is a prothrombin complex concentrate used to rapidly reverse the anticoagulant effect of warfarin, control acute bleeding caused by deficiencies of clotting factors II, VII, IX, or X, and replace deficient protein C or protein S in patients with acquired or congenital deficiencies.
How does Human Prothrombin Complex Concentrate work?+
The preparation supplies the vitamin K‑dependent clotting factors II, VII, IX, and X together with regulatory proteins C and S. By raising their plasma levels, it re‑initiates the coagulation cascade, generating thrombin and restoring normal clot formation while also helping regulate anticoagulant pathways.
What is the usual dose of Octaplex?+
Dosing of Octaplex is individualized. The prescribing clinician determines the amount based on the patient’s INR, the severity of bleeding, body weight, and the specific clinical scenario. No fixed regimen can be stated without a medical order.
Is Octaplex safe in pregnancy or breastfeeding?+
Safety data for Octaplex in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.
How do I order Octaplex from GNH USA?+
To order Octaplex, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling) and necessary import documentation.
How does Octaplex compare with other reversal agents?+
Octaplex provides a broad spectrum of vitamin K‑dependent factors plus proteins C and S, offering more comprehensive replacement than single‑factor concentrates or vitamin K alone. Compared with recombinant factor VIIa, it restores multiple clotting steps but may carry a higher thrombotic risk, requiring careful patient selection.
How should Octaplex be stored and handled?+
Octaplex must be stored refrigerated at 2‑8 °C. Keep the vial in its original container, protect it from light, and avoid freezing or shaking. Prior to use, inspect for particulates and ensure the solution is at room temperature before intravenous administration.
How is Octaplex administered?+
Octaplex is given as an intravenous infusion. The dose is diluted in a compatible solution and infused over a period determined by the prescriber, usually under close monitoring of coagulation parameters and vital signs during and after the injection.
What are the most serious risks associated with Octaplex?+
The most serious adverse events include thromboembolic complications such as deep‑vein thrombosis or pulmonary embolism, disseminated intravascular coagulation, severe allergic reactions including anaphylaxis, and, theoretically, transmission of infectious agents from the plasma source.
Who should not receive Octaplex?+
Octaplex is contraindicated in patients with known hypersensitivity to any of its plasma‑derived components, in those with active, uncontrolled disseminated intravascular coagulation, and in individuals for whom the risk of thrombosis outweighs the clinical benefit, as determined by the treating physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F
Route
Intravenous Use
Manufacturer
Octapharma (Ip) Sprl
Origin
EU